152 related articles for article (PubMed ID: 34220837)
1. Influence of Tumor Immune Infiltration on Immune Checkpoint Inhibitor Therapeutic Efficacy: A Computational Retrospective Study.
Liu R; Yang F; Yin JY; Liu YZ; Zhang W; Zhou HH
Front Immunol; 2021; 12():685370. PubMed ID: 34220837
[TBL] [Abstract][Full Text] [Related]
2. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors.
Ding L; Sun L; Bu MT; Zhang Y; Scott LN; Prins RM; Su MA; Lechner MG; Hugo W
Front Immunol; 2023; 14():1176994. PubMed ID: 37435085
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model.
Pezeshki A; Cheville JC; Florio AB; Leibovich BC; Vasmatzis G
Front Immunol; 2024; 15():1356144. PubMed ID: 38605943
[TBL] [Abstract][Full Text] [Related]
4. Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic Stratification.
Chen Y; You S; Li J; Zhang Y; Kokaraki G; Epstein E; Carlson J; Huang WK; Haglund F
Front Immunol; 2021; 12():788959. PubMed ID: 35069566
[TBL] [Abstract][Full Text] [Related]
5.
Chen Y; Huang Y; Gao X; Li Y; Lin J; Chen L; Chang L; Chen G; Guan Y; Pan LK; Xia X; Guo Z; Pan J; Xu Y; Yi X; Chen C
Front Immunol; 2020; 11():1620. PubMed ID: 32903763
[No Abstract] [Full Text] [Related]
6. Circadian tumor infiltration and function of CD8
Wang C; Zeng Q; Gül ZM; Wang S; Pick R; Cheng P; Bill R; Wu Y; Naulaerts S; Barnoud C; Hsueh PC; Moller SH; Cenerenti M; Sun M; Su Z; Jemelin S; Petrenko V; Dibner C; Hugues S; Jandus C; Li Z; Michielin O; Ho PC; Garg AD; Simonetta F; Pittet MJ; Scheiermann C
Cell; 2024 May; 187(11):2690-2702.e17. PubMed ID: 38723627
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating immune cells and survival in head and neck squamous cell carcinoma: a retrospective computational study.
Zhang L; Wang WQ; Chen JH; Feng J; Liao YZ; Zou Y; Liu R
Sci Rep; 2024 Mar; 14(1):6390. PubMed ID: 38493212
[TBL] [Abstract][Full Text] [Related]
8. Combined Assessment of the Tumor-Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer.
Ravensbergen CJ; Polack M; Roelands J; Crobach S; Putter H; Gelderblom H; Tollenaar RAEM; Mesker WE
Cells; 2021 Oct; 10(11):. PubMed ID: 34831157
[TBL] [Abstract][Full Text] [Related]
9. Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy.
Horiguchi H; Kadomatsu T; Yamashita T; Yumoto S; Horino T; Sato M; Terada K; Miyata K; Ichigozaki Y; Kimura T; Fukushima S; Moroishi T; Oike Y
Cancer Gene Ther; 2024 Jun; 31(6):933-940. PubMed ID: 38467764
[TBL] [Abstract][Full Text] [Related]
10. The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro.
Presti M; Westergaard MCW; Draghi A; Chamberlain CA; Gokuldass A; Svane IM; Donia M
Cancer Immunol Immunother; 2021 Jun; 70(6):1771-1776. PubMed ID: 33165629
[TBL] [Abstract][Full Text] [Related]
11. Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies.
Gorgulho J; Roderburg C; Beier F; Bokemeyer C; Brümmendorf TH; Loosen SH; Luedde T
Br J Cancer; 2024 Apr; 130(6):1013-1022. PubMed ID: 38233492
[TBL] [Abstract][Full Text] [Related]
12. Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma.
Versluis JM; Hoefsmit EP; Shehwana H; Dimitriadis P; Sanders J; Broeks A; Blank CU
Cancer Immunol Immunother; 2024 Jan; 73(2):28. PubMed ID: 38280045
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in Sarcoma: Current Data and Promising Strategies.
Wood GE; Meyer C; Petitprez F; D'Angelo SP
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432234. PubMed ID: 38781557
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating γδ T cells as targets of immune checkpoint blockade in melanoma.
Di Simone M; Corsale AM; Toia F; Shekarkar Azgomi M; Di Stefano AB; Lo Presti E; Cordova A; Montesano L; Dieli F; Meraviglia S
J Leukoc Biol; 2024 Mar; 115(4):760-770. PubMed ID: 38324004
[TBL] [Abstract][Full Text] [Related]
15. Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma.
Bai X; Attrill GH; Gide TN; Ferguson PM; Nahar KJ; Shang P; Vergara IA; Palendira U; da Silva IP; Carlino MS; Menzies AM; Long GV; Scolyer RA; Wilmott JS; Quek C
Nat Commun; 2024 Apr; 15(1):3014. PubMed ID: 38589406
[TBL] [Abstract][Full Text] [Related]
16. Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses.
Tian J; Quek C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673829
[TBL] [Abstract][Full Text] [Related]
17. A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance.
Mitra A; Thompson B; Strange A; Amato CM; Vassallo M; Dolgalev I; Hester-McCullough J; Muramatsu T; Kimono D; Puranik AS; Weber JS; Woods D
Clin Cancer Res; 2023 Oct; 29(20):4242-4255. PubMed ID: 37505479
[TBL] [Abstract][Full Text] [Related]
18. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment.
Bender MJ; McPherson AC; Phelps CM; Pandey SP; Laughlin CR; Shapira JH; Medina Sanchez L; Rana M; Richie TG; Mims TS; Gocher-Demske AM; Cervantes-Barragan L; Mullett SJ; Gelhaus SL; Bruno TC; Cannon N; McCulloch JA; Vignali DAA; Hinterleitner R; Joglekar AV; Pierre JF; Lee STM; Davar D; Zarour HM; Meisel M
Cell; 2023 Apr; 186(9):1846-1862.e26. PubMed ID: 37028428
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Single-Cell and Spatial-Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy.
Liu C; Xie J; Lin B; Tian W; Wu Y; Xin S; Hong L; Li X; Liu L; Jin Y; Tang H; Deng X; Zou Y; Zheng S; Fang W; Cheng J; Dai X; Bao X; Zhao P
Adv Sci (Weinh); 2024 Jun; 11(23):e2401061. PubMed ID: 38569519
[TBL] [Abstract][Full Text] [Related]
20. Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.
Gil-Jimenez A; van Dijk N; Vos JL; Lubeck Y; van Montfoort ML; Peters D; Hooijberg E; Broeks A; Zuur CL; van Rhijn BWG; Vis DJ; van der Heijden MS; Wessels LFA
Nat Commun; 2024 Mar; 15(1):2538. PubMed ID: 38514623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
